STOCK TITAN

Sartorius Stock Price, News & Analysis

SARTF OTC Link

Company Description

Sartorius (OTC Link: SARTF) is a publicly traded medical instruments & supplies company in the Healthcare sector. The company has a market capitalization of $17.9B.

SARTF stock has gained 3.7% over the past year. Shares last traded at $226.33.

This page provides a comprehensive overview of SARTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
+3.68%
Performance 1 year
$17.9B

Sartorius (SARTF) stock last traded at $226.33. Over the past 12 months, the stock has gained 3.7%. At a market capitalization of $17.9B, SARTF is classified as a large-cap stock with approximately 34.2M shares outstanding.

Latest News

Sartorius has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings, dividends. View all SARTF news →

SEC Filings

No SEC filings available for SARTF.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

SEP
01
September 1, 2026 Product

Orders begin for Eveo

Orders open for Eveo Cell Therapy Platform; commercial ordering begins Sept 2026
JAN
01
January 1, 2027 - December 31, 2027 Product

First deliveries expected

First deliveries of Eveo platform expected during 2027; initial customer shipments anticipated
JAN
01
January 1, 2030 Corporate

2030 emissions reduction target

42% Scope 1&2 CO₂e and 51.6% Scope 3 intensity reductions; SBTi-validated
JAN
01
January 1, 2045 Corporate

Net-zero target 2045

Ambition for climate-neutral value chain and net-zero by 2045; tied to Executive Board pay

Sartorius has 4 upcoming scheduled events. The next event, "Orders begin for Eveo", is scheduled for September 1, 2026 (in 131 days). Investors can track these dates to stay informed about potential catalysts that may affect the SARTF stock price.

Short Interest History

Last 12 Months

Short interest in Sartorius (SARTF) currently stands at 617 shares, down 1.8% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 78.4%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Sartorius (SARTF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 1964.4% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 10.9 to 1000.0 days.

SARTF Company Profile & Sector Positioning

Sartorius (SARTF) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the OTC Link.

Investors comparing SARTF often look at related companies in the same sector, including Sartorius (SOAGY), Sartorius Ag Pfd (SUVPF), Sartorius AG (SSSGY), Straumann Hlding (SAUHY), and Sartorius Stedim (SDMHF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SARTF's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Sartorius (SARTF)?

The current stock price of Sartorius (SARTF) is $226.33 as of April 21, 2026.

What is the market cap of Sartorius (SARTF)?

The market cap of Sartorius (SARTF) is approximately 17.9B. Learn more about what market capitalization means .